Valuation: OraSure Technologies, Inc.

Market Cap 263M 226M 211M 193M 364M 25.23B 368M 2.5B 972M 12.67B 989M 968M 41.91B P/E 2026 *
-5.79x
P/E 2027 * -4.72x
Enterprise Value 263M 226M 211M 193M 364M 25.23B 368M 2.5B 972M 12.67B 989M 968M 41.91B EV / Sales 2026 *
2.16x
EV / Sales 2027 * 1.98x
Free-Float
93.63%
Yield 2026 *
-
Yield 2027 * -
1 day+0.13%
1 week+1.47%
Current month-6.05%
1 month-3.91%
3 months-3.43%
6 months+35.89%
Current year+57.23%
1 week 3.65
Extreme 3.65
3.93
1 month 3.65
Extreme 3.65
4.24
Current year 2.33
Extreme 2.33
4.58
1 year 2.08
Extreme 2.08
4.58
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
13.57
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 04/06/2022
Director of Finance/CFO 54 08/08/2022
Chief Tech/Sci/R&D Officer - 01/12/2024
Director TitleAgeSince
Director/Board Member 59 01/06/2020
Director/Board Member 66 08/11/2021
Director/Board Member 52 04/06/2022
Date Insider Type Main position Quantity % Market Cap.
1/3/26 Free

Controller/Auditor

72,044 0.1004%
1/3/26 Free

Chief Executive Officer

663,267 0.9246%
1/3/26 Free

Chief Financial Officer

143,546 0.2001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.13%+1.47%+21.18%-40.92% 263M
-1.12%+2.16%-12.71%+10.46% 202B
-1.45%-0.85%-0.79%+11.10% 119B
+0.29%+3.14%+13.10%+81.67% 61.78B
+0.40%-5.32%+30.83%+55.98% 52.35B
-1.21%+4.20%-3.23%-32.73% 51.96B
-0.70%+0.90%+19.02%-10.27% 34.36B
+0.17%+2.21% - - 30.44B
-0.79%+1.27%+41.98%-10.85% 24.87B
+0.04%-0.90%-5.19%+24.89% 24.07B
Average -0.46%+1.33%+11.58%+9.93% 60.09B
Weighted average by Cap. -0.82%+2.83%+2.06%+16.96%

Financials

2026 *2027 *
Net sales 122M 105M 97.9M 89.5M 169M 11.69B 171M 1.16B 450M 5.87B 458M 449M 19.43B 133M 114M 107M 97.64M 184M 12.75B 186M 1.26B 491M 6.4B 500M 489M 21.19B
Net income -46.2M -39.59M -37.04M -33.86M -63.9M -4.42B -64.58M -438M -170M -2.22B -173M -170M -7.35B -57.65M -49.41M -46.22M -42.26M -79.75M -5.52B -80.59M -547M -213M -2.77B -216M -212M -9.17B
Net Debt - -
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
26/08/26 USD 3.805 -0.39% 44,756
24/08/26 USD 3.820 -1.55% 348,092
21/08/26 USD 3.880 +3.74% 769,339
20/08/26 USD 3.740 +1.08% 647,424
19/08/26 USD 3.700 -1.33% 419,152
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.820USD
Average target price
4.000USD
Spread / Average Target
+4.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OSUR Stock